There is currently a biobank of surplus bloods, blood components & extracted genetic material from around 125,000 consented surplus bloods representing 74,000 individuals (as of April 2021) that covers a broad range of disease areas across NHS Fife, NHS Grampian & NHS Tayside.

 Genotyping is ongoing using the IIIumina Global Screening Array on a project specific basis. Applications to provide large scale genotyping are encouraged. In addition, these samples may be analysed in conjunction with the GoDARTS cohort of diabetes and controls 

Genotyping is ongoing using the IIIumina Global Screening Array on a project specific basis. Applications to provide large scale genotyping are encouraged. In addition, these samples may be analysed in conjunction with the GoDARTS cohort of diabetes and controls

Genotyping is ongoing using the IIIumina Global Screening Array on a project specific basis. Applications to provide large scale genotyping are encouraged. In addition, these samples may be analysed in conjunction with the GoDARTS cohort of diabetes and controls